He received both his MD and PhD from the University of Illinois, and his MBA from UCLA Anderson. Ilya founded a Clinical Research organization that conducted clinical trials of pharmaceutical drugs. He has completed several clinical trials as a Principal Investigator and is a co-inventor of Immix's cancer therapeutic platform technology.